Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1056288 PITTSBURGH, PA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,301,201
+$3,247,912 QoQ
Shares Held
462,205
+27.1% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 207 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $277,187,959 across 31 Drug Manufacturers - Specialty & Generic names. AMLX ranks #10 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 816,187 $65,074,589
2 INDV
Indivior Pharmaceuticals, Inc.
 1,468,749 $60,262,769
3 ELAN
Elanco Animal Health Inc
 1,543,944 $37,996,460
4 IRWD
Ironwood Pharmaceuticals Inc
 3,231,238 $13,603,511
5 AQST
Aquestive Therapeutics, Inc.
 3,112,561 $12,948,253
6 NBIX
Neurocrine Biosciences Inc
 76,569 $12,904,938
7 ALKS
Alkermes plc.
 221,589 $11,611,263
8 XERS
Xeris Biopharma Holdings, Inc.
 1,434,433 $11,360,709

All Filings in AMLX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,301,201 462,205
2026-03-31 $5,053,289 363,546
2025-12-31 $5,525,536 457,412
2025-09-30 $2,886,229 212,379
2025-06-30 $1,307,191 203,930
2025-03-31 $717,858 202,785
2024-12-31 $764,754 202,316
2024-09-30 $603,566 186,286
2024-06-30 $339,670 178,774
2024-03-31 $499,791 175,983
2023-12-31 $1,508,800 102,500
2023-09-30 $5,937,200 324,260
2023-06-30 $32,980,530 1,529,000
2023-03-31 $54,165,072 1,846,117
2022-12-31 $59,668,522 1,614,845
2022-09-30 $37,411,350 1,329,000